257 related articles for article (PubMed ID: 26169362)
1. Locally ablative treatment of breast cancer liver metastases: identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study).
Seidensticker M; Garlipp B; Scholz S; Mohnike K; Popp F; Steffen I; Seidensticker R; Stübs P; Pech M; PowerskI M; Hass P; Costa SD; Amthauer H; Bruns C; Ricke J
BMC Cancer; 2015 Jul; 15():517. PubMed ID: 26169362
[TBL] [Abstract][Full Text] [Related]
2. A comparison of laparoscopic radiofrequency ablation versus systemic therapy alone in the treatment of breast cancer metastasis to the liver.
Taşçi Y; Aksoy E; Taşkın HE; Aliyev S; Moore H; Ağcaoğlu O; Birsen O; Siperstein A; Berber E
HPB (Oxford); 2013 Oct; 15(10):789-93. PubMed ID: 24028270
[TBL] [Abstract][Full Text] [Related]
3. Clinical Effect of Percutaneous Radiofrequency Ablation for Residual Lung Metastases from Breast Cancer After Systemic Chemotherapy.
Wang Y; Lu X; Wang Y; Zhou J
J Coll Physicians Surg Pak; 2015 Aug; 25(8):602-5. PubMed ID: 26305308
[TBL] [Abstract][Full Text] [Related]
4. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
[TBL] [Abstract][Full Text] [Related]
5. Intra-arterial Mitomycin C infusion in a large cohort of advanced liver metastatic breast cancer patients: safety, efficacy and factors influencing survival.
Aarts BM; Klompenhouwer EG; Dresen RC; Laenen A; Beets-Tan RGH; Punie K; Neven P; Wildiers H; Maleux G
Breast Cancer Res Treat; 2019 Aug; 176(3):597-605. PubMed ID: 31065871
[TBL] [Abstract][Full Text] [Related]
6. Resection of liver metastases in patients with breast cancer: survival and prognostic factors.
van Walsum GA; de Ridder JA; Verhoef C; Bosscha K; van Gulik TM; Hesselink EJ; Ruers TJ; van den Tol MP; Nagtegaal ID; Brouwers M; van Hillegersberg R; Porte RJ; Rijken AM; Strobbe LJ; de Wilt JH;
Eur J Surg Oncol; 2012 Oct; 38(10):910-7. PubMed ID: 22682709
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous computed tomography-guided high-dose-rate brachytherapy ablation of breast cancer liver metastases: initial experience with 80 lesions.
Collettini F; Golenia M; Schnapauff D; Poellinger A; Denecke T; Wust P; Riess H; Hamm B; Gebauer B
J Vasc Interv Radiol; 2012 May; 23(5):618-26. PubMed ID: 22525020
[TBL] [Abstract][Full Text] [Related]
8. CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer.
Jakobs TF; Hoffmann RT; Schrader A; Stemmler HJ; Trumm C; Lubienski A; Murthy R; Helmberger TK; Reiser MF
Cardiovasc Intervent Radiol; 2009 Jan; 32(1):38-46. PubMed ID: 18575933
[TBL] [Abstract][Full Text] [Related]
9. Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT).
Collettini F; Lutter A; Schnapauff D; Hildebrandt B; Puhl G; Denecke T; Wust P; Gebauer B
Rofo; 2014 Jun; 186(6):606-12. PubMed ID: 24407711
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation combined with systemic chemotherapy in nasopharyngeal carcinoma liver metastases improves response to treatment and survival outcomes.
Jin Y; Cai YC; Cao Y; Cai XY; Tan YT; Shi YX; Jiang WQ
J Surg Oncol; 2012 Sep; 106(3):322-6. PubMed ID: 22271524
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation of concomitant and recurrent pulmonary metastases after surgery for colorectal liver metastases.
Chua TC; Al-Alem I; Zhao J; Glenn D; Liauw W; Morris DL
Ann Surg Oncol; 2012 Jan; 19(1):75-81. PubMed ID: 21710327
[TBL] [Abstract][Full Text] [Related]
12. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
[TBL] [Abstract][Full Text] [Related]
13. Clinical scenarios associated with local recurrence after laparoscopic radiofrequency thermal ablation of colorectal liver metastases.
Aksoy E; Aliyev S; Taskin HE; Birsen O; Mitchell J; Siperstein A; Berber E
Surgery; 2013 Oct; 154(4):748-52; discussion 752-4. PubMed ID: 24074411
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease.
Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH
Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366
[TBL] [Abstract][Full Text] [Related]
15. Hepatic arterial infusion chemotherapy for extensive liver metastases of breast cancer: efficacy, safety and prognostic parameters.
Tewes M; Peis MW; Bogner S; Theysohn JM; Reinboldt MP; Schuler M; Welt A
J Cancer Res Clin Oncol; 2017 Oct; 143(10):2131-2141. PubMed ID: 28646261
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation of colorectal liver metastases downstaged by chemotherapy.
Knudsen AR; Kannerup AS; Mortensen FV; Nielsen DT
Acta Radiol; 2009 Sep; 50(7):716-21. PubMed ID: 19488894
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates.
Meloni MF; Andreano A; Laeseke PF; Livraghi T; Sironi S; Lee FT
Radiology; 2009 Dec; 253(3):861-9. PubMed ID: 19709994
[TBL] [Abstract][Full Text] [Related]
18. [CT-guided radiofrequency ablation of liver metastases from colorectal cancer].
Mahnken AH; Bruners P; Tacke JA; Günther RW
Dtsch Med Wochenschr; 2009 May; 134(19):976-80. PubMed ID: 19401962
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for longer disease free survival and overall survival after surgical resection of isolated liver metastasis from breast cancer.
Zegarac M; Nikolic S; Gavrilovic D; Jevric M; Kolarevic D; Nikolic-Tomasevic Z; Kocic M; Djurisic I; Inic Z; Ilic V; Santrac N
J BUON; 2013; 18(4):859-65. PubMed ID: 24344009
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency ablation in the management of liver metastases from breast cancer.
Sofocleous CT; Nascimento RG; Gonen M; Theodoulou M; Covey AM; Brody LA; Solomon SM; Thornton R; Fong Y; Getrajdman GI; Brown KT
AJR Am J Roentgenol; 2007 Oct; 189(4):883-9. PubMed ID: 17885061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]